We are live on ! Find out more
SK

Seth Klarman Baupost Group

AUM $5.42B
1-Year Est. Return 22.93%
 

Seth Klarman is the founder and CEO of the Baupost Group, one of the most respected value-oriented investment firms. He is the author of Margin of Safety and is known for patient, opportunistic capital allocation across equities, credit, and special situations. Klarman’s approach emphasizes downside protection, cash when opportunities are scarce, and independent thinking when markets become crowded.

This Fund
S&P 500
This Quarter Est. Return
-0%
1 Year Est. Return
+22.93%
3 Year Est. Return
+47.86%
5 Year Est. Return
+25.7%
10 Year Est. Return
+163.46%
AUM
$5.74B
AUM Growth
-$399M
Cap. Flow
-$192M
Cap. Flow %
-3.35%
Top 10 Hldgs %
85.05%
Holding
28
New
3
Increased
6
Reduced
3
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 44.59%
2 Energy 22.16%
3 Healthcare 13.8%
4 Consumer Discretionary 6.19%
5 Financials 3.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MU icon
1
Micron Technology
MU
$1.09T
$1.77B 30.82%
51,655,434
LNG icon
2
Cheniere Energy
LNG
$57.3B
$896M 15.61%
11,199,030
+5,211,100
+87% +$397M
VSAT icon
3
Viasat
VSAT
$10.3B
$636M 11.07%
11,533,137
EBAY icon
4
eBay
EBAY
$46.3B
$345M 6.01%
14,485,776
+3,945,127
+37% +$87.8M
INVA icon
5
Innoviva
INVA
$1.52B
$339M 5.9%
19,815,983
-579,073
-3% -$13.3M
KERX
6
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$252M 4.38%
18,300,000
+7,760,014
+74% +$119M
ONIT
7
Onity Group
ONIT
$301M
$183M 3.19%
+466,780
New +$211M
PBF icon
8
PBF Energy
PBF
$8.72B
$171M 2.99%
7,145,418
+1,550,132
+28% +$40.9M
AR icon
9
Antero Resources
AR
$11.7B
$151M 2.64%
+2,759,510
New +$160M
TBPH icon
10
Theravance Biopharma
TBPH
$883M
$140M 2.43%
6,061,228
VRTV
11
DELISTED
VERITIV CORPORATION
VRTV
$118M 2.06%
+2,362,885
New +$100M
C.WS.A
12
DELISTED
Citigroup Inc
C.WS.A
$116M 2.03%
122,573,007
RFMD
13
DELISTED
RF MICRO DEVICES INC
RFMD
$113M 1.96%
9,759,185
TQNT
14
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
$112M 1.95%
5,880,696
SEMI
15
DELISTED
SunEdison Semiconductor Limited
SEMI
$80.2M 1.4%
4,145,379
IMOS
16
ChipMOS TECHNOLOGIES
IMOS
$1.88B
$74.3M 1.29%
2,979,654
NG icon
17
NovaGold Resources
NG
$3.83B
$65.7M 1.14%
21,688,300
KOS icon
18
Kosmos Energy
KOS
$1.76B
$47.3M 0.82%
4,750,000
ELOS
19
DELISTED
Syneron Medical Ltd
ELOS
$30M 0.52%
2,994,610
-1,005,390
-25% -$10.2M
KIN
20
DELISTED
Kindred Biosciences, Inc.
KIN
$27.9M 0.49%
3,013,848
+250,000
+9% +$3.38M
AIG.WS
21
DELISTED
American International Group, Inc.
AIG.WS
$18.8M 0.33%
788,998
AOI
22
DELISTED
Alliance One International
AOI
$12.6M 0.22%
638,364
BYD icon
23
Boyd Gaming
BYD
$5.87B
$9.95M 0.17%
979,476
-1,815,154
-65% -$19.7M
ALDW
24
DELISTED
Alon USA Partners LP
ALDW
$5.83M 0.1%
329,188
TMQ
25
Trilogy Metals
TMQ
$684M
$5.54M 0.1%
6,005,298
+1,000,000
+20% +$1.06M

Similar funds

Seth Klarman's Q3 2014 Portfolio in Review

As of Q3 2014, Seth Klarman held 28 positions worth $5.74B, down 6.5% from $6.14B the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Seth Klarman withdrew a net $192M in Q3 2014, closing 1 position and reducing 3 holdings. Its most notable exit was IDENIX PHARMACEUTICALS INC, an estimated $1.27B position sold in full.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 41% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Seth Klarman opened a new position in Onity Group worth $183M.

  • Seth Klarman's largest Q3 2014 buy was Onity Group: 466,780 shares worth $183M.
  • Seth Klarman added most to Cheniere Energy in Q3 2014, an estimated $397M increase.
  • Seth Klarman's biggest Q3 2014 reduction was Boyd Gaming, cutting an estimated $19.7M.
  • Seth Klarman fully exited IDENIX PHARMACEUTICALS INC in Q3 2014, selling an estimated $1.27B.
  • Seth Klarman's ten largest holdings make up 85% of its $5.74B portfolio in Q3 2014.
  • Seth Klarman opened 3 new positions and closed 1 in Q3 2014.
  • Seth Klarman's portfolio value fell 6.5% quarter-over-quarter to $5.74B.

Based on Baupost Group's 13F filing for Q3 2014, filed 14 Nov 2014.